menu search

Apellis' (apls) earnings top, empaveli sales boost revenues

Apellis pharmaceuticals (APLS) reports better-than-expected results, beating both earnings and revenue ...

February 22, 2023, 3:03 pm

Ionis pharmaceuticals, inc. (ions) q4 2022 earnings call transcript

Ionis pharmaceuticals, Inc. (NASDAQ:IONS ) Q4 2022 Results Conference Call February 22, 2023 11:30 AM E...

February 22, 2023, 2:57 pm

Should you buy alnylam pharmaceuticals (alny) ahead of earnings?

Alnylam pharmaceuticals (ALNY) is seeing favorable earnings estimate revision activity and has a positi...

February 22, 2023, 12:03 pm

Ionis pharmaceuticals (ions) reports q4 loss, misses revenue estimates

Ionis pharmaceuticals (IONS) delivered earnings and revenue surprises of 65.09% and 3.82%, respectively...

February 22, 2023, 9:47 am

Analyst confidence in eli lilly boosted by product pipeline

Eli Lilly and Company (NYSE: LLY) is one of the most recognized names in the pharmaceutical industry. I...

February 22, 2023, 9:01 am

Spotlite360 iot solutions terminates agreement with e3 service group

SpotLite360 IOT Solutions (CSE:LITE) said it has terminated its agreement and relationship with E3 Service Group LLC, a facilities design and environ...

February 22, 2023, 8:05 am

Aytu biopharma to report second quarter fiscal 2023 financial results on february 21, 2023

ENGLEWOOD, CO / ACCESSWIRE / February 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage ...

February 21, 2023, 3:00 pm

Biocryst pharmaceuticals, inc. (bcrx) q4 2022 earnings call transcript

BioCryst pharmaceuticals, Inc. (NASDAQ:BCRX ) Q4 2022 Earnings Conference Call February 21, 2023 8:30 A...

February 21, 2023, 1:00 pm

Why biocryst pharmaceuticals stock is sinking today

Investors didn't like the drugmaker's Q4 update....

February 21, 2023, 11:55 am

Biocryst pharmaceuticals (bcrx) reports q4 loss, tops revenue estimates

BioCryst (BCRX) delivered earnings and revenue surprises of -100% and 6.11%, respectively, for the quarter ended December 2022. Do the numbers hold cl...

February 21, 2023, 9:47 am

Algernon pharmaceuticals says unit initiates traumatic brain injury research program with dmt; appoints global tbi expert as advisor

Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Ne...

February 21, 2023, 9:09 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutica...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutica...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutica...

February 21, 2023, 8:00 am

Should you invest in the vaneck pharmaceutical etf (pph)?

Sector ETF report for PPH...

February 21, 2023, 7:32 am

Altimmune to report fourth quarter and full year 2022 financial results and provide business update on february 28, 2023

GAITHERSBURG, Md., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharma...

February 21, 2023, 7:30 am

In8bio to present at the h.c. wainwright cell therapy virtual conference

NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical...

February 21, 2023, 7:00 am

Verona pharma to report fourth quarter and full year 2022 financial results and provide corporate update

LONDON and RALEIGH, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-st...

February 21, 2023, 2:00 am

Indivior sell-off ignores its solid long term potential, says leading broker

Indivior PLC (LSE:INDV)'s solid fundamentals have been overshadowed by market concerns about a $290m legal provision, according to Jefferies. Despite ...

February 20, 2023, 12:16 pm

3 dirt-cheap stocks to buy sooner rather than later

These pharmaceutical stocks probably won't stay so attractively valued for too much longer....

February 18, 2023, 8:14 am


Search within

Pages Search Results: